Hospital Acquired Infection Control Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Hospital Acquired Infection Control Market is segmented by Product, Indication, End User, and Geography

Market Snapshot

Hospital Acquired Infection Control Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The hospital acquired infection control market is expected to witness a CAGR of 7.3% during the forecast period. Certain factors that have been driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, a rise in the incidences of different types of hospital-acquired infections, and innovative technologies implemented in devices that control infection.

  • Hospital acquired infections are usually caused by pathogens, which spread at a very fast rate in the body. Due to the patients’ weak immune system and poor conditions in a hospital, the infections spread at a greater speed than the normal infections. 
  • These infections have been treated by taking antibiotics, by following a proper and healthy diet, and by encouraging the natural healing process. The infection can be prevented by keeping the hospital facility premises clean. 
  • The most common type of hospital acquired infections is a urinary tract infection. The increase in incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital-acquired infections are some of the factors that have been driving the growth of the studied market.

Scope of the Report

Hospital acquired infections are also called nosocomial infections and have been acquired in hospitals and other healthcare facilities. These infections can occur up to 48 hours after hospital admission or up to three days after discharge or up to 30 days after an operation or in a healthcare facility when the patient was admitted for reasons other than an infection.

Product
Sterilants
Heat Sterilization Equipment
Low Temperature Sterilization Equipment
Radiation Sterilization Equipment
Steam Sterilization
Other Sterilants
Disinfectants
Other Products
Indication
Hospital Acquired Pneumonia
Bloodstream Infections
Surgical Site Infections
Gastrointestinal Infections
Urinary Tract Infections
Other Indications
End User
Hospitals and Intensive Care Units
Ambulatory Surgical and Diagnostic Centers
Nursing Homes and Maternity Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Disinfectant is Expected to Hold Significant Market Share in the Product Type

Disinfection is referred to as a process, which eliminates many or all pathogenic microorganisms, except the bacterial spores from inanimate objects. This is accomplished by the use of liquid chemicals or wet pasteurization. The efficiency of disinfection has been affected by several factors, each of which may limit the efficacy of the process. Some of the factors, which have been shown to affect disinfection efficacy are the earlier cleaning of the object, the organic load on the item, the type and level of microbial impurity, the physical configuration of the object (e.g., crevices, hinges, and lumens), the concentration of exposure time to the germicide, and the pH and temperature of the disinfection process. The US FDA (Food and Drug Administration) maintains a list of high-level disinfectants that can be used to reprocess heat-sensitive medical devices, such as flexible endoscopes.

Hospital Acquired Infection Control Market

North America Dominates the Market and Expected to do Same in the Forecast Period

According to the Centers for Disease Control and Prevention (CDC), even though significant progress has been made in stopping some healthcare-associated infection types from spreading, there is still much more work to be done. On any given day, in the United States, around one in 31 hospital patients has at least one healthcare-associated infection. North America, especially the United States and Canada, has made significant progress toward the collective goal of abolishing these HAIs, and as a result, healthcare in this region has become safer now than it was even 10 years ago. Building upon this success and continuing toward the elimination of hospital-acquired infections is critical, and this has contributed to the largest market share of North America.

Hospital Acquired Infection Control Market

Competitive Landscape

The hospital acquired infection control market is highly competitive and consists of several players. Companies, like 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux Sa, Cantel Medical, Ethicon, Getinge Group, Kimberly-Clark Corporation, Sterigenics International LLC, and Steris Corporation, among others, hold the substantial market share in the hospital acquired infection control market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Hospital Stay Due to Chronic Diseases and Surgeries

      2. 4.2.2 Rise in the Incidences of Different Types of Hospital Acquired Infections

      3. 4.2.3 Innovative Technologies Implemented in Devices that Control Infection

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness Regarding Hospital Acquired Infection

      2. 4.3.2 Stringent Regulatory Requirements

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product

      1. 5.1.1 Sterilants

        1. 5.1.1.1 Heat Sterilization Equipment

        2. 5.1.1.2 Low Temperature Sterilization Equipment

        3. 5.1.1.3 Radiation Sterilization Equipment

        4. 5.1.1.4 Steam Sterilization

        5. 5.1.1.5 Other Sterilants

      2. 5.1.2 Disinfectants

      3. 5.1.3 Other Products

    2. 5.2 Indication

      1. 5.2.1 Hospital Acquired Pneumonia

      2. 5.2.2 Bloodstream Infections

      3. 5.2.3 Surgical Site Infections

      4. 5.2.4 Gastrointestinal Infections

      5. 5.2.5 Urinary Tract Infections

      6. 5.2.6 Other Indications

    3. 5.3 End User

      1. 5.3.1 Hospitals and Intensive Care Units

      2. 5.3.2 Ambulatory Surgical and Diagnostic Centers

      3. 5.3.3 Nursing Homes and Maternity Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 3M Company

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Fortive Corporation

      4. 6.1.4 Metall Zug Group (Belimed)

      5. 6.1.5 Cantel Medical

      6. 6.1.6 Getinge AB

      7. 6.1.7 Sotera Health

      8. 6.1.8 STERIS PLC

      9. 6.1.9 S. C. Johnson & Son Inc.

      10. 6.1.10 Tuttnauer

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hospital Acquired Infection Control Market market is studied from 2018 - 2026.

The Hospital Acquired Infection Control Market is growing at a CAGR of 7.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

3M Company, Becton, Dickinson and Company, Biomerieux SA, Ethicon, Sterigenics International LLC are the major companies operating in Hospital Acquired Infection Control Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!